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Effectivity of flavonoids on animal model psoriasis –
thermographic evaluation
Abstract
Background and purpose: Psoriasiform lesions are characterized by hy-
perproliferation and aberrant differentiation of epidermal keratinocytes,
accompanied by inflammation, leading to a disrupted skin barrier with an
abnormal stratum corneum. Psoriasis is a chronic inflammatory disease
whose etiopathogenesis has not yet been fully resolved, and therefore there is
no standardized therapeutical approach. This study examined the possible
positive effects of propolis and its polyphenolic/flavonoid compounds on an-
imal model psoriasis, induced by the Di-n-Propyl Disulfide iritant (PPD),
and the possibility to assess usefulness of thermography in psoriatic lesion re-
gression.
Material and methods: We monitored the inflammation process by
monitoring the total number of inflammatory cells in peritoneal cavity,
macrophage spreading index and thermographic scanning. Thermographic
is scanning an effective and simple method which reproducibly records ther-
mographic images of the examined area. The tested animals were divided
into sixteen groups and locally processed during five days with PPD, water
and ethanolic extract (WSDP or EEP) of propolis preparations and fla-
vonoids (Epigallocatechin 3-gallate, Quercetin, Chrisin, Curcumin).
Results: The results of thermal imaging showed no statistically signifi-
cant differences in temperature changes on skin locuses of psoriasis formed
lesions among the examined groups. The total number of inflammatory
cells in peritoneal cavity and the macrophage spreading index were reduced
in psoriatic mice treated with test components.
Conclusions: These results demonstrate that topical application of pro-
polis and the flavonoids present in propolis may improve psoriatic-like skin
lesions by suppressing functional activity of macrophages and ROS produc-
tion. Taken toghether, it is suggested that propolis and flavonoids offer some
protection against psoriatic complications through their roles as inhibitors
of inflammation and as free radical scavengers. Thermal imaging was real-
istic, and can be applicable in examining the inflammatory process in psori-
asis and in evaluating the effectiveness of tested substances.
INTRODUCTION
Psoriasis is a chronic, recurrent, inflammatory skin disease whichmanifests by multiple erithematosquamous plaques, and it affects
1–3% of the general population (1, 2). It is understood today that the
disease incures as a result of interplay between genetic and surrounding
factors (3). However, the immunopathogenic mechanisms of psoriasis,
as well as optimal therapeutical approach, are yet to be fully resolved (4,
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5). That is why, despite the development in new drug
groups, traditional therapy is still used although its toxic-
ity and negative side effects are well known (5).
Scientific information supports the view that an in-
sufficient antioxidant system contributes to the patho-
genesis of psoriasis (6). In psoriatic skin context, reactive
species are generated by keratinocytes and activated leu-
kocytes, mostly neutrophils (7). Psoriatic skin is also
characterized by an advanced state of lipid peroxidation
(8). Thus, it has been suggested that the antioxidant
treatment could be part of a more specific and effective
therapy for the management of this skin disease (9). Re-
cent literature data continue to support the fact that
polyphenolic compounds, found in most plants and bee
products, can have a positive effect on many chronic dis-
eases (10-13). Natural polyphenols, recognized as potent
antioxidants, are multifunctional molecules that can act
as anti-inflammatory (14) and antiproliferative agents
(15) through the modulation of multiple signaling path-
ways. This characteristic could be advantageous for the
treatment of multi-causal diseases, such as psoriasis. Poly-
phenols are ubiquitous constituents of plants and possess
a broad spectrum of biological activities such as immune
system activities (11, 16-18), oxygen radical scavenging
(19-21), antimicrobial (22), anti-inflammatory (10) and
antitumor activities (10, 11, 23, 24).
We therefore tried to investigate the possible positive
effects of natural antioxidants, propolis and its poly-
phenolic/flavonoid compounds on animal model psoria-
sis, induced by the Di-n-Propyl Disulfide irritant (PPD),
during 5 days (25). Taking into account that the basic
pathohistologic properties of psoriasis, such as hypekera-
tosis, inflammatory infiltrates and cardiovascular chan-
ges, can induce significant changes in skin temperature,
we used thermographic imaging to monitor inflamma-
tory reactions and the effectivity of tested compounds
(26-28). In fact, many studies have shown that blood
flow in psoriatic lesions is up to 10 times greater than in
clinicaly normal skin, which leads to skin temperature
increase (29). Thermography is an efficient and simple
method which successfully and reproducibly records ther-
mal images of tested arreas, and is widely used in diag-
nostics and treatment of diseases (e.g. malignant diseases
like breast cancer and melanoma, and sclerodermia, osteo-
arthritis, rheumatoid arthritis, psoriasis and psoriatric ar-
thritis, Raynauds phenomenon etc...), as well as different
experimental studies, including possible effects and ap-
plication of new compounds (28, 30-35). The develop-
ment of new technologies and state-of-the-art thermovi-
sion cameras enabled thermovision inspection in numer-
ous branches of science and industry. A typical new gen-
eration camera is the ThermoTracer TH7102WL (NEC
San-ei Instruments, 2004.), with its uncooled sensor ele-
ments, and with which all the measurements in this
study were done. The remote control and measuring us-
ing the WEB (ThermoWEB) are based on an expansion
of the measuring and operable usage possibilities of the
thermovision camera NEC Thermo tracer TH7102WL,
and are used for operating, controling and assaying the
images obtained in the process of thermal imaging of
people, animals, etc. Because of its specific quantitative
display in the field of medical processing, ThermoMed is
used exclusively for images done with the ThermoWEB
system (36). The aim of this study was to employ ther-
mography in assessing the inflammatory skin changes
and effectivity of flavonoids on animal model psoriasis.
MATERIAL AND METHODS
Animals
The present study was approved by the ethical com-
mittee (Faculty of Science, University of Zagreb, Croa-
tia). Male Swiss albino mice 2 to 3 months old, weighing
20 to 25 g, obtained from Department of Animal Physiol-
ogy, Faculty of Science, University of Zagreb, were used
in this study. The animals were kept in individual cages
during the experiment and at 12 hours of light per day.
They were fed a standard laboratory diet (4 RF 21, Mu-
cedola, Settimo Milanese, Italy) and given tap water ad
libitum. Maintenance and care of all experimental ani-
mals were carried out according to the guidelines in force
in the Republic of Croatia (Law on the Welfare of Ani-
mals, N.N. #19, 1999) and carried out in compliance
with the Guide for the Care and Use of Laboratory Ani-
mals, DHHS Publ. # (NIH) 86-123.
Di-n-Propyl Disulfide
We used the Di-n-Propyl Disulfide irritant manufac-
tured by Sigma-Aldrich Corporation, USA.
Water-soluble derivative of propolis
(WSDP)
Water-soluble derivative of propolis (WSDP) was pre-
pared by the method described in our previous paper
(16). Briefly, Croatian propolis from beehives kept at the
outskirts of Zagreb was extracted with 96% ethanol, and
then the preparation was filtered and evaporated to dry-
ness in vacuum evaporator. The resultant resinous prod-
uct was added to a stirred solution of 8% L-lysine (Sigma
Chemie, Deisenhofen, Germany) and freeze-dried to
yield the WSDP, a yellow-brown powder.
The chemical profile of propolis from the northern
hemisphere, often named as »poplar-type« propolis can
be characterized by three analytical parameters: total
flavonol and flavone content, total flavanone and dihy-
droflavonol content, and total polyphenolic content. Ac-
cording to Popova et al. (37), spectrophotometric proce-
dures for quantification of the three main groups of
bioactive substances in propolis could be used for quality
assessment of different propolis samples, and results of
those analyses correlate with biological activity, espe-
cially in the »poplar-type« of propolis. The spectrophoto-
metric assay based on the formation of aluminum chlo-
ride complex was applied for quantification of total flavo-
nes/flavonols and expressed as Quercetin equivalent. For
the quantification of flavanones and dihydroflavonols in
propolis, we used 2,4-dinitrophenylhydrazine method
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(38). Total polyphenolic content was measured by the
Folin-Ciocalteu procedure (19). WSDP contained: fla-
vones and flavonols: 2.13%, flavanones and dihydrofla-
vonols: 9.06%, total flavonoids: 11.19%, total polyphe-
nols: 70.48%.
Ethanolic extract of propolis (EEP)
Raw Croatian propolis was collected by scraping it off
from hive frames. The collected propolis samples were
kept desiccated in the dark until analysis at room temper-
ature. Ethanolic propolis extract (EEP) was prepared by
the method described elsewhere (39). Briefly, propolis
(10 g) was crushed into small pieces in a mortar and
mixed vigorously with 34.85 mL 80% (V/V) ethanol dur-
ing 48 h at 37 ± 1°C. After extraction, the ethanolic ex-
tract of propolis was filtered through Whatman N0.4 pa-
per and then the extract was lyophilized. Spectrophoto-
metric analysis showed that EEP contained: flavones
and flavonols: 1.6%, flavanones and dihydroflavonols:
38.60%, total flavonoids: 40.20%, total polyphenols:
84.40%.
Flavonoids
Epigallocatechin 3-gallate (EGCG) manufactured by
Shanghai Angoal Chemical Co., Ltd., China; Curcumin
and Chrysin, manufactured by Sigma-Aldrich Corpora-
tion, USA; Quercetin, manufactured by Fluka Chemie
GmbH, Switzerland.
Induction of psoriatic skin lesions and
application of test components
Di-n-Propyl Disulfide was used as an irritant as pre-
viously reported (40). Topical 5% propolis preparation
or flavonoid application are relevant for evaluating the
efficacy of test components in in vivo animal model, as
reported previously in a study by Noh et al. (41). Test
components (100 mg) were dissolved in 2 mL ace-
tone/olive oil (1:1). The day before the trials were about
to start, all animals had had an area of ~3 cm shaved on
their abdomen.
Brifly, 30 mL Di-n-Propyl Disulfide was painted onto
the surface of the shaved abdomen of mice during 5 days.
During the one-time topical application on the skin of
the tested animals, we used 30 mL of solution, and the
analysis lasted 5 days. The animals were divided into 16
groups: the first group consisted of mice that were topi-
cally treated only with Di-n-Propyl Disulfide; the second
group consisted of mice that were simultanously ana-
lysed with Di-n-Propyl Disulfide and the solution; the
next 6 groups consisted of mice that were simultanously
treated with Di-n-Propyl Disulfide and the Water-solu-
ble derivative of propolis, WSDP (group 3), Ethanolic
extract of propolis, EEP (group 4), EGCG (group 5),
Quercetin (group 6), Chrysin (group 7) and Curcumin
(group 8); further 6 groups consisted of mice that were
treated solely with compounds of WSDP (group 9), EEP
(group 10), EGCG (group 11), Quercetin (group 12),
Chrysin (group 13) and Curcumin (group 14); group 15
consisted of mice treated solely with the solution, and
group 16 of untouched mice (healthy control). All ani-
mals were numbered within the group, and every group
was in its separate cage with the label of the group on it.
During 5 days, every animal was topically treated with its
specific compound on the abdomen. The thermographic
imaging was run on the 3rd and 5rd day of trials, specifi-
cally on animals’ abdomens.
Thermoscan aquisition and data
analysis
The room in which the thermographic imaging is
done has to be air-conditioned, and the temperature of
the measuring area must not oscillate more than ±1°C.
Cages with laboratory animals were brought into the
room 2 hours before the measuring, so that the animals
can acclimatize to the room temperature. The tempera-
ture difference between the rooms was not more than
3°C in favor of the room in which the animals were
placed (barn).
All thermographic imaging was done by using the
same television camera, in the same room, using the
same computer programme, and by the same examiner
Darko Kolari}, PhD, a research associate from the Cen-
ter for Informatics and Computing, Ru|er Bo{kovi} In-
stitute, who used the ThermoMED programme (36).
Every image had a marked circle of the tested locus on
the abdomen, and the lowest, the highest, and average
sample temperatures were noted within the circle. The
basic statistical analysis (the lowest temperature, highest
temperature, mean, standard error, interquartile range)
was run over those circled measurements, either single or
in groups. A p value equal to 0.05 or less was considered
statistically significant.
For the statistical analysis of the obtained dana, the R
Version 2.10.1 statistical programme was used (Develop-
ment Core Team. R: A language and environment for
statistical computing. R Foundation for Statistical Com-
puting, Vienna, Austria, 2009.).
Count of the total number of cells
present in the peritoneal cavity
After disinfection of the external abdominal region,
each animal was inoculated with 3 mL of saline solution
and after gentle agitation of the abdominal wall, the so-
lution containing peritoneal cells was removed for cellu-
lar evaluation.The total number of cells present in the
peritoneal cavity was determined by counting in a Bür-
ker-Türk chamber.
Determination of the functional activity
of macrophages
The functional activity of macrophages in the peri-
toneal cavity was determined by the spreading technique
(18) Thus, 103 cells in 0.1 mL of the cellular suspension
obtained from the peritoneal cavity were placed in dupli-
cate over glass cover slips at room temperature for 15
min. The non-adherent cells were removed by washing
with phosphate buffered saline, and the adherent cells
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were incubated in culture medium 199 containing 10
nM HEPES at 37°C for 1 h. Following this, the culture
medium was removed and the cells were fixed with 2.5%
glutaraldehyde. Then the cells were stained with a 5%
Giemsa solution and examined by optical microscopy
where the percentage of spread cells were determined us-
ing a ´40 objective. The spread cells were those that ex-
hibited cytoplasmic elongation, while the non-spread
cells were rounded (18) Using an ocular grid, 200
macrophages were scored as either round or spread. An
index of macrophage spreading (SI) was then calculated
for each monolayer of each glass cover slips, as follows:
SI = (number of spreading macrophages ´ 100) / 200 ad-
herent cells, i.e. SI = % of spreading macrophages.
RESULTS
The thermographic imaging
Results of the thermographic imaging showed no sig-
nificant difference between the tested groups in tempera-
ture changes on the skin with the psoriasiform lesions on
the animal model. In comparing the first and second
thermographic measurings, no statistically significant
differences between the groups were noticed. Detailed
data is presented in Figures 1 and 2. Examples of the first
and second measuring of a single animal from the group
tested with PPD combined with Curcumin are presented
in Figures 3 and 4.
Effect of propolis preparations and their
flavonoids on the total number of peritoneal
cells and functional activity of macrophages
in PPD-induced psoriatic mice
The results (Table 1) showed no significant difference
between PPD and PPD +solvent (vehicle) while a statis-
tically significant reduction was observed in the total
number of inflammatory cells in the peritoneal cavity of
experimental psoriatic mice treated with WSDP (P <
0.05). Other psoriatic groups topically treated with test
components showed a lower total number of inflamma-
tory cells without statistical diference. In addition, a sta-
tistically significant difference exists between nonpso-
riatic animals (P < 0.05) treated with test components
and PPD group. Psoriatic mice treated with WSDP do
not show any statistically significant differences as com-
pared with nonpsoriatic mice.
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Figure 1. Results of the first thermographic measuring of tested ani-
mals topically processed with PPD and the compounds of propolis
and/or flavonoids.
Figure 2. Results of the second thermographic measuring of tested an-
imals topically processed with PPD and the compounds of propolis
and/or flavonoids.
Figure 3. Thermographic display of the first measuring of abdominal
skin, the first sample from the group processed with PPD combined
with Curcumin.
The results presented in Table 1 indicated statistically
significant increase in the percent of activated macro-
phages in PPD mice (P < 0.05) compared with mice
treated with PPD in combination with test components.
The percentages of functional activated macrophages in
psoriatic mice treated with test components and non-
psoriatic mice treated with test component were equal.
DISCUSSION
Today thermographic imaging has a great variety of
uses in medicine, from research and diagnostics of many
diseases to observing their path and assesing the effe-
ctivity of new compounds, especially in conditions char-
acterized by an increased blood flow or inflammation de-
velopment, such as psoriasis (29). However, although
litarature data on thermography use in psoriasis dates
back to the 1970’s, the thermographic systems of that era
couldn’t support quality research following today’s stan-
dards (42). Ippolito et al. used thermography as a method
of assessing the effectivity of cyclosporine treatment, and
Zalewska et al. investigated the effectivity of thermogra-
phy in assessing the activity of psoriatic lesions (30, 31).
Our thermographic imaging results showed no statis-
tically significant difference between the tested groups in
temperature changes on the skin with the psoriasiform
lesions on the animal model. Furthermore, in comparing
the first and second thermographic measurings, no sta-
tistically significant differences between the groups were
observed. Considering the short irritation time, during
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Figure 4. Thermographic display of the second measuring of the ab-
dominal skin, the first sample from the group processed with PPD
combined with Curcumin.
TABLE 1.
Total cells number and macrophage spreading in the peritoneal cavity of mice topically treated with PPD or propolis prepa-
rations and/or its flavonoids alone or in combination
Experimental groupa
Total N0 of cells in peritoneal
cavity ´ 103 (mean ± SE)
Macrophage spreading
index (%)
PROPIL DISULFID (PPD) 6796.87 ± 866.45# 67.50 ± 2.63#
PPD + solvent (vehicle) 5038.97 ± 1401.40 61.00 ± 1.30#
PPD + WSDP 2871.09 ± 868.43* 45.50 ± 2.50*
PPD + EEP 4921.87 ± 1111.74 48.00 ± 2.45*
PPD + EGCG 4277.37 ± 1071.38 38.50 ± 4.99*
PPD + QUERCETIN 4335.94 ± 803.40 32.00 ± 6.88*
PPD + CHRYSIN 4628.90 ± 889.26# 54.00 ± 4.55*
PPD + CURCUMIN 3808.59 ± 996.09 36.50 ± 6.24*
WSDP 6914.06 ± 564.77# 48.50 ± 3.86*
EEP 2656.25 ± 563.37* 38.67 ± 5.81*
EGCG 4687.50 ± 993.34 54.67 ± 4.81
QUERCETIN 2890.62 ± 563.37* 46.00 ± 9.16
CHRYSIN 2109.37 ± 703.12* 36.67 ± 3.53*
CURCUMIN 1484.37 ± 434.98* 28.67 ± 5.81*
CONTROL +solvent (vehicle) 2031.25 ± 546.88* 42.67 ± 2.91*
CONTROL 1796.87 ± 340.54* 31.33±7.05*
a Mice were treated topically with PPD or test components (WSDP, EEP, EGCG, quercetin, chrysin, curcumin) alone or in combina-
tion for 5 consecutive days.
* Statistically significantly different compared to PPD (P<0.05)
 Statistically significantly different compared to the corresponding combination with PPD (P <0.05)
# Statistically significantly different compared to solvent control (P <0.05)
which the inflammatory reaction probably could not de-
veloped, the obtained results can be considered as ex-
pected. Also, based on commonly known physiological
properties of mice (their normal body temperature is be-
tween 36.5°C and 38°C), we conclude that significant
changes in the inflammatory reaction could not be no-
ticed. In their research, Maleszka et al. found that the
hyperkeratonic lesions were hypothermic and therefore
assumed that a serious skin infiltration, which leads to
epidermal hypertrophy, could act as an isolation layer
and cause a certain decrease in temperature (43). Zale-
wska et al. also divided psoriatic lesions into 4 groups, de-
pending on their locality on the patients body, and no-
ticed an increase in temperature in the chest and upper
extremities in contrast to a decrease in the lower extremi-
ties (34). In our recearch we topically applied the tested
compounds to the abdomen of the experimental animals,
which is their lower body area, and therefore our results
corresponded with the mentioned research. In addition,
the total number of inflammatory cells in peritoneal cav-
ity of psoriatic mice treated with test components were
reduced without statical significant difference, expect for
the grup treated with WSDP. The positive effect of test
components was not only related to inflammatory cell
infiltrates but also to significantly fewer macrophages
spreading index in the abdominal cavity as a marker of
inflammation induced by ROS generated by keratino-
cytes and activated leukocytes, mostly neutrophils (7).
Dietary antioxidant compounds, including propolis and
its flavonoids, offer some protection against psoriatic
complications through their roles as inhibitors of inflam-
mation and as free radical scavengers (10-12, 20, 21).
There has been a growing interest in flavonoids which
are widely distributed in plants and ingested by humans,
due to their antioxidative, mild estrogenic, hypolipide-
mic, antibacterial, antitumor, anti-inflammatory, anti-
diarrhoeal, antiulcer, antimutagenic, myocardial protect-
ing, vasodilator, immunomodulator and hepatoprotective
activities (10-12). Such remarkable spectrum of bioche-
mical and cellular functions holds promise for the pre-
vention and treatment of a variety of human disorders
caused by oxidative stress, including psoriasis.
From the obtained data, we can conclude that the
measured values were expected, which is to say that the
thermal camera realistically registered thermal images
and is an applicable method in assessing the inflamma-
tory process in psoriasis. However, further investigation
is necessary to confirm the obtained results.
CONCLUSIONS
The study implies that propolis and its flavonoids
could be used as natural therapeutic drugs to prevent or
treat psoriatic complications. Thermography seems to be
a sensitive and realistic method, and can be applicable in
examining of the inflammatory process in psoriasis and
in evaluating the effectiveness of tested substances.
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